Sodium hyaluronate eyedrops in the treatment of dry eyes. - Wikidata - awgldk - TriplyDB

Sodium hyaluronate eyedrops in the treatment of dry eyes.

Sodium hyaluronate eyedrops in the treatment of dry eyes.

http://www.wikidata.org/entity/Q34368785

about

Ophthalmic Uses of a Thiol-Modified Hyaluronan-Based Hydrogel Trehalose protects corneal epithelial cells from death by drying Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis.The application of in vivo laser scanning confocal microscopy as a tool of conjunctival in vivo cytology in the diagnosis of dry eye ocular surface disease.Evaluation of lipid oxidative stress status and inflammation in atopic ocular surface disease.The effect of topical amiloride eye drops on tear quantity in rabbits Eosinophil cationic protein as a marker for assessing the efficacy of tacrolimus ophthalmic solution in the treatment of atopic keratoconjunctivitis Longitudinal assessment of optical quality and intraocular scattering using the double-pass instrument in normal eyes and eyes with short tear breakup time Donor-recipient gender difference affects severity of dry eye after hematopoietic stem cell transplantation Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome.Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjögren's syndrome patients JBP485 promotes tear and mucin secretion in ocular surface epithelia.Albumin as a tear supplement in the treatment of severe dry eye.Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study Randomized, Multicenter, Double-Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease Preliminary report of improved sleep quality in patients with dry eye disease after initiation of topical therapy Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye Topical Application of Apricot Kernel Extract Improves Dry Eye Symptoms in a Unilateral Exorbital Lacrimal Gland Excision Mouse.A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye.Changing trends in the treatment of dry-eye disease.Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome.Combining Sodium Hyaluronate and Polyvinylpyrrolidone Therapies for the Rabbit Cornea: A New Approach to Relief of the Human Dry Eye Syndrome.Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial.Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye.Inflammatory cells in brush cytology samples correlate with the severity of corneal lesions in atopic keratoconjunctivitis.Phytosome-hyaluronic acid systems for ocular delivery of L-carnosine.Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro.The impact of tear functions on visual outcome following keratoplasty in eyes with keratoconus.A Prospective, Randomized Trial of Two Mucin Secretogogues for the Treatment of Dry Eye Syndrome in Office Workers.KfoA, the UDP-glucose-4-epimerase of Escherichia coli strain O5:K4:H4, shows preference for acetylated substrates.A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore.Comparative study of 0.1% hyaluronic acid versus 0.5% carboxymethylcellulose in patients with dry eye associated with moderate keratitis or keratoconjunctivitis.Influence of Sodium Hyaluronate Concentration on Corneal Aberrations in Soft Contact Lens Wearers.Comparison of 0.1%, 0.18%, and 0.3% Hyaluronic Acid Eye Drops in the Treatment of Experimental Dry Eye

P2860

Q27014963-7EC4EC5C-51C1-4152-9B57-FEFF7FB413DB Q28363468-E62D73D4-16CB-4700-955E-7543F550AE9C Q33553643-60891C6F-F5FC-4EBA-8BE1-068FDDE38A9A Q33765579-66E65E1C-9239-49A1-9D32-9873DA95AF20 Q34366061-611B8838-91BD-42B7-B9CC-43ACF840F55B Q34366101-0287065F-3285-4C71-98E1-0254EF40BB76 Q34882570-6C52119B-589D-4867-B378-AA9934AB09E4 Q35064188-CCC1B5DE-1A21-4FCA-AAE5-E1AB636979FC Q35226797-C5E86C99-B2E9-45DF-941C-53E038F3CD1A Q35307717-055933C4-AA61-4B33-8831-2358BD9F8CE4 Q35589451-2D9A2CE6-1FB4-4DE8-A103-424B8BE160A0 Q35589881-FCC2D07B-9AD6-4C27-A83A-10CDDE5B95A8 Q35633676-0A3B4839-C656-4F4E-B711-006148321030 Q35895180-461BD194-1FBC-41A9-BDA3-E04BB862621E Q36048835-B2915CA0-05F1-4CB4-A1C9-F228D1459B66 Q36296284-898182A0-F36A-4AD4-8199-1A927DB4B44A Q36313759-BF6435B8-6568-4DA1-840A-9B45D904D745 Q36569538-69CA2375-54D1-4181-88AE-69229EA5C005 Q36603961-FB1623B9-4953-4339-B81C-17CDFC679FAB Q37070035-4838D609-E25B-4747-A2DA-AE1C31EA6E0D Q37463430-E6C3CF76-19DC-41E8-9166-345EDAD2A708 Q37676992-AEADFDA8-BBFC-467E-87DE-BC5251FFACF0 Q38148616-03CFE135-D116-4B72-A668-B0172FD4F367 Q38209468-57FBCA54-0BF5-4A2A-876F-876C4905E646 Q39199618-972E0BD7-9818-4291-8111-5515380A97D0 Q40997622-A56B1913-1930-4F8D-8026-CE2FB409CB1D Q41813800-7F5F3FBD-DA03-4363-AC6F-810ECE4C5ADE Q42108471-24C8F6D6-A59E-43A1-BB67-EBC77FA61646 Q42578623-11BD56D2-A828-4030-87A2-1382C52C1741 Q43007758-2D1F4798-40D7-4AE3-AF88-9370222A58E0 Q44264873-DED7B912-1969-4CA0-8C6E-771E9866334F Q47121635-6D52C831-0D41-458A-962D-C6B150C94746 Q47328575-37433839-84C9-466E-BF1F-9ECB7D0417F7 Q53625697-867D9F87-97D4-42C0-9060-7F97663F7000 Q55250864-F05C8CDF-1355-413F-8930-0853B737E197 Q55260596-000A963D-1BCF-4284-8D45-169D8F45E808 Q58771513-663667A1-4EE2-450F-873E-971AE107F31A

P2860

Sodium hyaluronate eyedrops in the treatment of dry eyes.

http://www.wikidata.org/entity/Q34368785

description

1995 nî lūn-bûn

@nan

1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Sodium hyaluronate eyedrops in the treatment of dry eyes.

@ast

Sodium hyaluronate eyedrops in the treatment of dry eyes.

@en

Sodium hyaluronate eyedrops in the treatment of dry eyes.

@nl

type

label

Sodium hyaluronate eyedrops in the treatment of dry eyes.

@ast

Sodium hyaluronate eyedrops in the treatment of dry eyes.

@en

Sodium hyaluronate eyedrops in the treatment of dry eyes.

@nl

prefLabel

Sodium hyaluronate eyedrops in the treatment of dry eyes.

@ast

Sodium hyaluronate eyedrops in the treatment of dry eyes.

@en

Sodium hyaluronate eyedrops in the treatment of dry eyes.

@nl

P1433

Q34368785-0D12D0C2-0275-4186-869F-54CFEE3BCAB9

P1476

Q34368785-E22E8EB7-B450-423B-A7A8-748C5CEF7BE2

P2093

Q34368785-4D0820E8-786A-4ED9-B87B-C3A9D50A060F

Q34368785-74834ABC-F675-4B85-A105-C2EC96A9D332

Q34368785-7799FA30-F53F-4FCC-B5D5-6AF4A4D46FAB

Q34368785-7AED2759-9151-42B8-BDD6-FD33C11E890B

Q34368785-9025D179-684F-4386-BC1F-1D6AF3D033EA

Q34368785-943A744B-7980-4803-AC76-A3A2914BD39C

Q34368785-C3C7C7B9-8A74-4907-A43A-0651E3DCDA8E

P2860

Q34368785-2961D772-B5D4-439D-B424-8E1AFD697CF6

Q34368785-5D671190-C15B-4272-A97D-613CC6D34F51

Q34368785-5ECC87A8-53A1-43A4-A8FE-A3FC2185BE0D

Q34368785-6D4976EB-470F-4964-B23E-39DCDEFBA408

Q34368785-984A12E5-E83D-46E0-86D2-3265AA8FFCB9

Q34368785-C14A930A-D137-4654-AEFA-6E6C1898740E

Q34368785-DDD04771-C707-4755-9730-FC874FDF6B73

Q34368785-DE9E06B8-F701-47F8-BAFC-5D3374A0AFDF

Q34368785-FCDFC4F0-8612-4BDC-B659-E4CEA6266E80

P304

Q34368785-2A8AA4B5-FEF0-49B4-BBFC-C20206B04801

P31

Q34368785-A60543A8-86F6-4BC7-B454-1DD026A0B644

P356

Q34368785-784FECD8-EA95-45C4-A2A8-274A099DFDC0

P407

Q34368785-9A0EAF3E-CE94-4537-8BDD-19EB5A9C453A

P433

Q34368785-D48EE745-8574-4C39-A7EE-01331C1C3EC3

P478

Q34368785-E8BCC152-9B1D-46EA-B20A-B616825A4F2D

P577

Q34368785-A1E80687-4653-499B-8F08-01FA43E99A68

P5875

Q34368785-3C574810-CE81-47B5-9511-E1570A711B4C

P698

Q34368785-F646BAB8-F683-45E0-86BE-7A6B3891E7FC

P932

Q34368785-91EB79C8-C909-431B-9822-47505F08881A

P356

P1433

British Journal of Ophthalmology

P1476

Sodium hyaluronate eyedrops in the treatment of dry eyes.

@en

P2093

Mashima Y

http://www.w3.org/2001/XMLSchema#string

Ono M

http://www.w3.org/2001/XMLSchema#string

Shimmura S

http://www.w3.org/2001/XMLSchema#string

Shinozaki K

http://www.w3.org/2001/XMLSchema#string

Takamura E

http://www.w3.org/2001/XMLSchema#string

Toda I

http://www.w3.org/2001/XMLSchema#string

Tsubota K

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of sodium hyaluronate (0.1%) on break-up time (NIBUT) in patients with dry eyes

Sjögren's syndrome. Proposed criteria for classification.

Fibronectin promotes epithelial migration of cultured rabbit cornea in situ.

Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca.

Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial.

Hyaluronan stimulates corneal epithelial migration.

Conjunctival cytologic features of primary Sjögren's syndrome.

Tear evaporation from the ocular surface.

Comparison of fluorescein and rose bengal staining.

P304

1007-1011

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJO.79.11.1007

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P577

1995-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14665139

http://www.w3.org/2001/XMLSchema#string

P698

8534643

http://www.w3.org/2001/XMLSchema#string

P932

505317

http://www.w3.org/2001/XMLSchema#string